Soc. Generale Discount Zert SAX 2.../ DE000SW12AG3 /
27/06/2024 08:36:25 | Chg.+0.01 | Bid09:03:01 | Demandez à09:03:01 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
31.70EUR | +0.03% | 31.70 Bid taille: 750 |
- Ask la taille: - |
STROEER SE + CO. KGA... | - - | 27/09/2024 | Call |
GlobeNewswire
12:40
Cellectar Biosciences to Host Key Opinion Leader Event to Review the Full Results from Its CLOVER Wa...
GlobeNewswire
12:30
X4 Pharmaceuticals Announces Positive Interim Clinical Data from Ongoing Six-Month Phase 2 Trial of ...
GlobeNewswire
12:30
Medigene Presents Efficient 6-Day TCR-T Therapy Production Process with High Stemness
GlobeNewswire
12:00
Entero Therapeutics Announces Peer-Reviewed Publication Unveiling Novel Algorithm for Measuring Inte...
GlobeNewswire
12:00
Nightfood Holdings Inc. New Subsidiary, Future Hospitality Ventures, Solves Hospitality Labor Crisis
GlobeNewswire
12:00
Action1 Achieves CSA STAR Level 1 Certification and Signs CISA's Secure by Design Pledge
GlobeNewswire
12:00
Nkarta Initiates Clinical Trial of NKX019 in Lupus Nephritis with First Patient in Screening and Ann...
GlobeNewswire
12:00
FUTUREFUEL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed A...
GlobeNewswire
12:00
GenVivo Announces Initiation of Patient Dosing in a US Phase I/Ib Clinical Trial Evaluating GEN2, a ...
GlobeNewswire
12:00
Interlock Launches ThreatSlayer Web3 Security Extension and Incentivized Crowdsourced Internet Secur...
GlobeNewswire
12:00
LanzaTech and LanzaJet Introduce CirculAir™, a Revolutionary and Commercially Ready Solution to Conv...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page